【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 9
2 Introduction 11
2.1 What Is This Report About? 11
3 Definitions of Markets/Categories Covered 12
3.1 Dental Devices 12
3.1.1 CAD/CAM Dental Systems 12
3.1.2 Crowns and Bridges 12
3.1.3 Dental Implants 12
4 Company Snapshot 13
4.1 Key Facts 13
4.2 Company Overview 13
4.3 Financial Performance 13
4.4 SWOT Snapshot 13
5 Business Description 14
5.1 Business Overview 14
5.2 Dental Solutions 14
5.2.1 Overview 14
5.2.2 Financials 15
5.2.3 Market View 15
5.3 Major Products and Services 15
5.3.1 Overview 15
6 History 16
7 SWOT Analysis 19
7.1 Overview 19
7.2 Nobel Biocare Holding AG Strengths 19
7.2.1 Broad Product Portfolio 19
7.2.2 Geographic Diversity 20
7.2.3 Emphasis on Research and Development 20
7.3 Nobel Biocare Holding AG Weaknesses 20
7.3.1 Low Debt to Equity Ratio 20
7.3.2 Financial Performance 20
7.3.3 Legal Proceedings 20
7.4 Nobel Biocare Holding AG Opportunities 21
7.4.1 New Product Launches 21
7.4.2 Growing Dental Devices Market 21
7.4.3 Growth in Emerging Markets 21
7.4.4 Growing Aged Population 22
7.5 Nobel Biocare Holding AG Threats 22
7.5.1 Competitive Landscape 22
7.5.2 Stringent Government Regulations 22
7.5.3 Rapid Technological Change 22
8 Competitors 23
9 Competitive Landscape 24
9.1 Dental Devices (CAD/CAM Dental Systems), Global, Market Share (%), 2011 24
9.2 Nobel Biocare Holding AG, Dental Devices (CAD/CAM Dental Systems), by Region, Market Share (2011) 26
9.3 Nobel Biocare Holding AG, Dental Devices (CAD/CAM Dental Systems), by Country, Market Share (2011) 27
9.4 Dental Devices (Crowns and Bridges),Global, Market Share (%), 2011 29
9.5 Nobel Biocare Holding AG, Dental Devices (Crowns and Bridges),by Region, Market Share (2011) 31
9.6 Nobel Biocare Holding AG, Dental Devices (Crowns and Bridges), by Country, Market Share (2011) 32
9.7 Dental Devices (Dental Implants),Global, Market Share (%), 2011 34
9.8 Nobel Biocare Holding AG, Dental Devices (Dental Implants),by Region, Market Share (2011) 36
9.9 Nobel Biocare Holding AG, Dental Devices (Dental Implants), by Country, Market Share (2011) 37
10 Nobel Biocare Holding AG Medical Equipment Market Share Analysis by Category 39
10.1 Nobel Biocare Holding AG, Dental Devices, Global, Category Revenue Share (2011) 39
10.2 Nobel Biocare Holding AG, Asia-Pacific, Category Revenue Share (2011) 41
10.2.1 Nobel Biocare Holding AG, Australia, Category Revenue Share (2011) 43
10.2.2 Nobel Biocare Holding AG, China, Category Revenue Share (2011) 45
10.2.3 Nobel Biocare Holding AG, India, Category Revenue Share (2011) 47
10.2.4 Nobel Biocare Holding AG, Japan, Category Revenue Share (2011) 49
10.2.5 Nobel Biocare Holding AG, Other Asia-Pacific, Category Revenue Share (2011) 51
10.3 Nobel Biocare Holding AG, Europe, Category Revenue Share (2011) 53
10.3.1 Nobel Biocare Holding AG, France, Category Revenue Share (2011) 55
10.3.2 Nobel Biocare Holding AG, Germany, Category Revenue Share (2011) 57
10.3.3 Nobel Biocare Holding AG, Italy, Category Revenue Share (2011) 59
10.3.4 Nobel Biocare Holding AG, Spain, Category Revenue Share (2011) 61
10.3.5 Nobel Biocare Holding AG, United Kingdom, Category Revenue Share (2011) 63
10.3.6 Nobel Biocare Holding AG, Other Europe, Category Revenue Share (2011) 65
10.4 Nobel Biocare Holding AG, Middle East and Africa, Category Revenue Share (2011) 67
10.5 Nobel Biocare Holding AG, North America, Category Revenue Share (2011) 69
10.5.1 Nobel Biocare Holding AG, Canada, Category Revenue Share (2011) 71
10.5.2 Nobel Biocare Holding AG, United States, Category Revenue Share (2011) 73
10.6 Nobel Biocare Holding AG, South and Central America, Category Revenue Share (2011) 75
10.6.1 Nobel Biocare Holding AG, Brazil, Category Revenue Share (2011) 77
10.6.2 Nobel Biocare Holding AG, Other South and Central America, Category Revenue Share (2011) 79
11 Key Employees 81
12 Key Employee Biographies 82
13 Company Statement 83
14 Locations And Subsidiaries 85
14.1 Head Office 85
14.2 Other Locations & Subsidiaries 85
15 Financial Deals Landscape 87
15.1 Nobel Biocare Holding AG, Deals Volume Summary, 2007 to YTD 2013 87
16 Nobel Biocare Holding AG Detailed Deal Summary 89
16.1 Partnerships 89
16.1.1 Materialise Dental Enters Into Licensing Agreement With Nobel Biocare 89
16.1.2 Ceragenix Pharma Signs An Agreement With Nobel Biocare 90
16.1.3 Nobel Biocare Enters Into An Agreement With XCPT 91
16.1.4 Nobel Biocare Holding Enters Into An Agreement With Ivoclar Vivadent 92
16.1.5 Nobel Biocare Enters Into Co-Development Agreement With Optical Metrology 93
16.1.6 Nobel Biocare Signs An Agreement With Stockholm University 94
16.1.7 Nobel Biocare Announces Public Offering Of Bonds For $136 Million 95
16.1.8 Nobel Biocare Holdings Completes Public Offering Of Convertible Bonds For $331 Million 96
16.2 Acquisition 97
16.2.1 Nobel Biocare Acquires BioCad Medical 97
16.2.2 Nobel Biocare Holding Acquires Medicim 98
16.2.3 Nobel Biocare Holding Acquires Implant Master 99
16.2.4 Nobel Biocare Acquires AlphaBioTec 100
17 Recent Developments 101
17.1 Strategy And Business Planning 101
17.1.1 Feb 23, 2010: Nobel Biocare Signs Partnership Agreement With Noritake 101
17.1.2 Jan 11, 2010: Nobel Biocare Establishes Preferred Partner Program With Ivoclar Vivadent 102
17.1.3 Feb 22, 2008: Nobel Biocare Establishes Own Sales Organization In Hungary 103
17.2 Financial Announcements 103
17.2.1 Nov 08, 2012: Nobel Biocare Reports Revenue Of €131m In Q3 2012 103
17.2.2 Aug 22, 2012: Nobel Biocare Reports Revenue Of €149m In Q2 2012 104
17.2.3 Apr 27, 2012: Nobel Biocare Reports Revenue Of €147.6m In Q1 2012 104
17.2.4 Feb 09, 2012: Nobel Biocare Reports Revenue Of €569.2m In 2011 105
17.2.5 Nov 08, 2011: Nobel Biocare Reports Revenues Of €128.2m In Q3 2011 106
17.2.6 Aug 12, 2011: Nobel Biocare Reports Revenues Of €142.9m In Q2 2011 107
17.2.7 Apr 28, 2011: Nobel Biocare Reports Revenues Of €143.5m In Q1 2011 109
17.2.8 Feb 17, 2011: Nobel Biocare Reports Revenues Of €576.6m In 2010 110
17.2.9 Nov 03, 2010: Nobel Biocare Reports Revenues Of €131.7m In Q3 2010 110
17.2.10 Aug 11, 2010: Nobel Biocare Reports Profit Of EUR19.59 Million In Q2 2010 111
17.2.11 Apr 28, 2010: Nobel Biocare Reports Net Profit Of EUR38.7 Million In Q1 2010 112
17.2.12 Feb 10, 2010: Nobel Biocare Reports Net Income Of EUR105.8 Million In 2009 113
17.2.13 Nov 04, 2009: Nobel Biocare Reports Net Profit Of EUR33.6 Million In Q3 2009 115
17.2.14 Oct 19, 2009: Nobel Biocare Appoints William (Bill) Ryan As President And General Manager, North America 116
17.2.15 Aug 12, 2009: Nobel Biocare Posts Revenues Of EUR153.5 Million In Q2 2009 116
17.2.16 Apr 29, 2009: Nobel Biocare Posts Net Profit Of EUR18 Million In Q1 2009 117
17.2.17 Feb 11, 2009: Nobel Biocare Reports 2008 Results 118
17.2.18 Nov 03, 2008: Nobel Biocare Reports 3Q 2008 Results 120
17.2.19 Aug 11, 2008: Nobel Biocare Reports 2Q 2008 Results 122
17.2.20 Apr 24, 2008: Nobel Biocare Reports Q1 2008 Results 124
17.2.21 Feb 11, 2008: Nobel Biocare Declares 2007 Results 125
17.2.22 Oct 30, 2007: Nobel Biocare Reports Q3 2007 Results 126
17.2.23 Aug 09, 2007: Nobel Biocare Reports Q2 2007 Results 128
17.2.24 Apr 26, 2007: Nobel Biocare Reports Q1 2007 Results 129
17.2.25 Feb 08, 2007: Nobel Biocare Reports 2006 Results 129
17.2.26 Oct 19, 2006: Nobel Biocare Reports Q3 2006 Results 130
17.2.27 Aug 10, 2006: Nobel Biocare Reports Q2 2006 Results 131
17.2.28 May 03, 2006: Nobel Biocare Approves Dividend 132
17.2.29 May 03, 2006: Nobel Biocare Reports Q1 2006 Results 132
17.3 Research And Development 133
17.3.1 Oct 24, 2007: Nobel Biocare Signs Agreement With College Of Dentistry To Develop Predoctoral Curriculum 133
17.3.2 Feb 01, 2007: Nobel Biocare And Stockholm University Signs Research Partnership Agreement 134
17.4 Corporate Communications 134
17.4.1 Jul 06, 2012: Nobel Biocare Announces Resignation Of Dirk Kirsten As CFO 134
17.4.2 Mar 06, 2012: Nobel Biocare Appoints Frank Mengis As Senior Vice President, Global Operations 134
17.4.3 Jul 04, 2011: Nobel Biocare Names Michel Orsinger New Chairman 135
17.4.4 Feb 16, 2011: Nobel Biocare Appoints Richard Laube As New CEO 135
17.4.5 Dec 01, 2010: Nobel Biocare Announces Executive Changes 136
17.4.6 Oct 25, 2010: Nobel Biocare Announces Resignation Of Robert Gottlander As Executive Vice President Key Account Management 136
17.4.7 Apr 05, 2010: Nobel Biocare Elects New Board Members 137
17.4.8 Jul 11, 2009: Nobel Biocare Chairman To Step Down By March 2010 137
17.4.9 Apr 29, 2009: Nobel Biocare Plans To Reduce Workforce In Q2 2009 137
17.4.10 Mar 05, 2008: Nobel Biocare Announces Management Changes 137
17.4.11 Feb 25, 2008: Nobel Biocare To Delist From OMX Exchange 138
17.4.12 Oct 15, 2007: Nobel Biocare Appoints Head Of Business Development & Strategic Planning 138
17.4.13 Jul 30, 2007: Nobel Biocare Appoints New CEO 138
17.4.14 May 03, 2006: Nobel Biocare Elects New Board Members 139
17.5 Legal and Regulatory 139
17.5.1 Jul 05, 2010: California Dentist Files Class Action Suit Against Nobel Biocare Holding 139
17.5.2 Sep 14, 2009: Nobel Biocare And Materialise Dental Settle Patent Dispute 139
17.5.3 Sep 03, 2008: Nobel Biocare Settles Lawsuit Against Keystone Dental 139
17.6 Product News 140
17.6.1 Oct 06, 2010: Nobel Biocare Launches Replace Select TC One-Stage Overdenture Solution 140
17.6.2 Jan 31, 2008: Nobel Biocare Distributes Updated Information To Regulatory Bodies And Customers On Nobeldirect One Piece Implant 140
17.6.3 Jan 31, 2008: Nobel Biocare Updates Information On NobelPerfect One-piece Implant 141
17.6.4 Oct 15, 2007: Procera Software Clinical Design 2.0 – Better Features For Enhanced Nobelguide Treatment Planning 141
17.6.5 Oct 15, 2007: Procera Software Lab Design 2.0 – Streamlined And Improved Productivity Means Greater Profitability 141
17.6.6 Feb 22, 2007: Nobel Biocare Introduced Its Procera Implant Bridge Zirconia 141
17.6.7 Feb 22, 2007: Nobel Biocare Introduces Its Procera Bridge Zirconia 141
17.7 Other Significant Developments 142
17.7.1 Nov 22, 2010: Nobel Biocare Extends Syndicated Loan Facility 142
17.7.2 Nov 17, 2010: Nobel Biocare Signs MOU To Support P-I Branemark Institute Bauru In Brazil 142
17.7.3 Jul 09, 2009: CSC signs IT services outsourcing contract with Nobel Biocare 142
17.7.4 Jul 09, 2009: CSC Signs Seven-Year IT Outsourcing Agreement With Nobel Biocare 143
17.7.5 Mar 18, 2009: Nobel Biocare Signs Syndicated Loan Facility With Six International Banks 143
18 Appendix 144
18.1 Research Methodology 145
18.2 Secondary Research 145
18.3 Primary Research 145
18.4 Models 146
18.5 Forecasts 146
18.6 Expert Panels 146
18.7 GlobalData Consulting 146
18.8 Currency Conversion 147
18.9 Contact Us 148
18.10 Disclaimer 148
【レポート販売概要】
■ タイトル：Nobel Biocare Holding AG：市場シェア分析■ 英文：Nobel Biocare Holding AG Market Share Analysis
■ 発行日：2013年2月28日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160529
■ 調査対象地域：グローバル
- 雲母の世界市場動向2014/2015The report presents a thorough study of mica, covering both global and regional markets. It aims to give a proper picture of the market, its trends, perspectives and opportunities. Comprehensive data showing mica worldwide production, consumption, trade statistics and prices are provided. Each country’s market overview covers the following: mica production in the country, major manufacturers, mica …
- Hypothyroidism：グローバル臨床試験レビューH2, 2013Hypothyroidism Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Hypothyroidism Global Clinical Trials Review, H2, 2013" provides data on the Hypothyroidism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hypothyroidism. It includes an overview of the trial numbers and their recruitment status as per …
- 電解質混合物の世界市場2019-2023About this market Introduction of flavored electrolyte mixes to drive market growth. Electrolyte mixes are a mix of electrolyte salts and are generally bland in taste. This taste of non-flavored electrolyte mixes is not appealing to children, one of the primary consumers of electrolyte mixes. Thus, many vendors are introducing flavored electrolyte mixes to cater to the changing taste and preferenc …
- ポリビニルアルコール（PVA）の世界市場分析：エンドユーザー別（紙、食品包装、建設、電子）、地域別（北アメリカ、ヨーロッパ、アジア太平洋、中南米、MEA）、セグメント予測、2014-2025The global polyvinyl alcohol (PVA) market is expected to reach USD 1.21 billion by 2025, according to a new report by Grand View Research, Inc. Increasing need for bio-based PVA alcohol products is key growth factor to drive polyvinyl alcohol market growth. In addition, rising demand from Asia Pacific region is further propelling the demand over the forecast period.PVA is a synthetic water-soluble …
- スモールセル、WiFi、DAS、クラウドRAN、HetNetデータ2014-2020（The Small Cells, WiFi, DAS, Cloud RAN & HetNet Datasheet: 2014～2020）Part of the “HetNet Bible: 2013 ? 2020”, this datasheet provides in-depth revenue forecasts on the small cells, carrier WiFi, Distributed Antenna Systems (DAS), cloud Radio Access Networks (RAN) and small cell backhaul. Market forecasts and historical revenue figures from 2010 till 2020 are provided for each of the following categories: Small Cells Carrier WiFi Small Cell Backhaul Small Cells as a …
- 世界の肺炎検査市場The report presents a detailed analysis of the Pneumonia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Pneumonia definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Comm …
- マイクロ・機械化灌漑システムの世界市場分析：製品別（スプリンクラー、ドリップ、中央ピボット、側方移動）、苗別（プランテーション作物、果樹園作物、畑作物）、用途別、セグメント予測、2014-2025The global micro & mechanized irrigation systems market is expected to reach USD 33.4 billion by 2025, according to a new study by Grand View Research, Inc. The low cost of micro and mechanized irrigation products is expected to fuel the market growth over the forecast period. The cost-saving benefits associated with micro and mechanized irrigation systems, such as chemigation and fertigation, fur …
- CMV検査の世界市場2015The report presents a detailed analysis of the Cytomegalovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the CMV definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals &nbs …
- アトピー性皮膚炎の疫学的予測（～2024）EpiCast Report: Atopic Dermatitis - Epidemiology Forecast to 2024 Summary Atopic dermatitis or atopic eczema is the most common type of eczema. Atopic dermatitis is a chronic inflammatory skin disease characterized by itchy skin lesions and rashes. Though the condition affects people of all ages, it is primarily common among infants and children. Risk factors for atopic dermatitis are broadly clas …
- 冷凍・冷蔵倉庫の世界市場2016-2020About the Refrigerated Warehousing Market Refrigerated warehouses are an important segment of the supply chain that involves the storage of temperature-sensitive goods. Refrigerated storage helps in the storage of perishable goods during the flow of the cold chain supply. The increase in international trade has increased the need for the storage of food products from the producers to end-users in …
- テニスラケットの世界市場2016-2020About Tennis Racquet While traditional tennis rackets were made of wood and strings, manufacturers now use carbon fiber and aluminum as primary raw materials. The size, design, length, stiffness of the frame, balance, and weight of a tennis racket play significant roles in enhancing player strength and performance. Manufacturers consider these features key to the successful R&D of these rackets an …
- パン改良剤の世界市場予測（～2022年）：乳化剤、酵素、酸化剤、還元剤“The bread improvers market is projected to grow at a CAGR of 5.2%”The bread improvers market is projected to reach USD 4.08 billion by 2022 at a CAGR of 5.2% from 2017 to 2022. The market is driven by factors such as the increasing consumption of bread and its related products, innovation in bakery products, demand for organic bread improvers, and increase in demand for convenience foods. “Emulsi …
- 段ボール原紙の北米市場2016-2020About Containerboard Containerboard is widely used for packaging different durable and non-durable goods. Containerboard packaging is a lighter, stronger, more durable, and cost-effective alternative to conventional packaging materials. Containerboard is classified into two broad categories such as recycled containerboard and virgin containerboard, which are produced using modified paper machines …
- 石油・ガス産業における三相分離装置の世界市場：横型セパレーター、縦型セパレーター、球形セパレーターAbout Global Three-phase Separator Market in the Oil and Gas Industry Crude oil is of two types: sweet crude oil and sour crude oil. Sweet crude is also referred to as light crude while sour crude is referred to as heavy crude. Based on composition, sweet or sour crude oil needs to be refined using different methods and technologies. At the time of production, crude oil stream consists of three-ph …
- グリコールの世界市場：製品別（エチレン、プロピレン）、用途別（自動車、HVAC、繊維、ポリエステル繊維・樹脂、航空会社）、セグメント予測The global glycols market size is projected to reach USD 47.26 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 6.7% during the forecast period. Recovering end-use industries in developed nations is a key driving factor for the market. Ethylene glycol is used in several applications that entail intermediaries for solvent couplers, resins, for freeze …
